Drug: Bevacizumab Injury: Neutropenia Quarter: 2016Q3
Total Records: 45 Number of Pages: 3
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 81331126 | Bevacizumab | Neutropenia | ROCHE | 0.00 | F | 0 | 20160912 | US |
| 89228356 | Bevacizumab | Neutropenia | ROCHE | 0.00 | 0 | 20160914 | US | |
| 100108357 | Bevacizumab | Neutropenia | ROCHE | 0.00 | 0 | 20160922 | US | |
| 110923303 | Bevacizumab | Neutropenia | ROCHE | 0.00 | 0 | 20160913 | IT | |
| 112724882 | BEVACIZUMAB | Neutropenia | ACTAVIS | 72.63 YR | M | 69 KG | 20160704 | IT |
| 115525913 | Bevacizumab | Neutropenia | ROCHE | 0.00 | 0 | 20160810 | JP | |
| 117884022 | Bevacizumab | Neutropenia | ROCHE | 0.00 | 0 | 20160906 | US | |
| 122161853 | Bevacizumab | Neutropenia | ROCHE | 0.00 | 0 | 20160907 | JP | |
| 123166492 | Bevacizumab | Neutropenia | ROCHE | 0.00 | 0 | 20160812 | FR | |
| 123978472 | Bevacizumab | Neutropenia | ROCHE | 0.00 | 0 | 20160831 | IT | |
| 124556852 | BEVACIZUMAB | Neutropenia | TEVA | 42.75 YR | F | 70 KG | 20160707 | IT |
| 125281901 | BEVACIZUMAB | Neutropenia | JANSSEN | 0.00 | 0 | 20160705 | US | |
| 125300961 | Bevacizumab | Neutropenia | CIPLA | 57.00 YR | M | 0 | 20160706 | FR |
| 125426441 | Bevacizumab | Neutropenia | CIPLA | 0.00 | 0 | 20160709 | US | |
| 125509871 | Bevacizumab | Neutropenia | ROCHE | 0.00 | 0 | 20160713 | GR | |
| 125550611 | Bevacizumab | Neutropenia | CIPLA | 0.00 | 0 | 20160714 | US | |
| 125732041 | Bevacizumab | Neutropenia | ROCHE | 0.00 | 0 | 20160720 | JP | |
| 125826361 | Bevacizumab | Neutropenia | ROCHE | 0.00 | 0 | 20160722 | US | |
| 126009073 | Bevacizumab | Neutropenia | ROCHE | 0.00 | 0 | 20160901 | US | |
| 126099531 | Bevacizumab | Neutropenia | ROCHE | 0.00 | 0 | 20160801 | US |
Total Records: 45 Number of Pages: 3